On a roll, Re­ci­pharm wraps up its sec­ond and third CD­MO ac­qui­si­tions this month

Re­ci­pharm is end­ing the month of Feb­ru­ary the same way it start­ed: with an ac­qui­si­tion. Two of them, to be pre­cise.

The Swedish com­pa­ny will bol­ster its CD­MO op­er­a­tions with the ac­qui­si­tions of Ar­ran­ta Bio and Viba­log­ics. The two deals will help give its CD­MO op­er­a­tions a bit more va­ri­ety for its clients, the com­pa­ny said in a re­lease. A rep­re­sen­ta­tive from Re­ci­pharm wasn’t avail­able for com­ment due to an in­ter­nal com­pa­ny town hall, a spokesper­son for the com­pa­ny said Thurs­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER